Results 11 to 20 of about 2,269 (86)

ФАРМАКОДИНАМИЧЕСКИЕ ЭФФЕКТЫ КАРДИОСЕЛЕКТИВНОГО В-АДРЕНОБЛОКАТОРА НЕБИВОЛОЛА У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА И МЕТАБОЛИЧЕСКИМ СИНДРОМОМ

Евразийский Кардиологический Журнал, 2019
Бета-адреноблокаторы (БАБ) рекомендуются большинству больных с различными формами ишемической болезни сердца (ИБС), однако их применение зачастую ограничивается различными факторами, в частности неблагоприятным метаболическим профилем. Цель.

doaj   +2 more sources

Клинические дилеммы: бета-адреноблокаторы при атеросклерозе

, 2023
Beta-blockers are the cornerstone of treatment for various cardiovascular conditions. Beta-blockers were discovered as antianginal drugs in the 1960s and are currently widely used in heart failure, arrhythmias, and ischemic heart disease. In this article,
POPESCU, Liuba, CARAUȘ, Alexandru, Anna Cotelea, Liuba Popescu, Anna Moiseeva, MOISEEVA, Anna, Alexandru Caraus, COTELEA, Ana   +7 more
core   +1 more source

Место бета-блокаторов в лечении артериальной гипертензии в 2017 году: так ли все плохо?

, 2022
Эта статья является обзором данных литературы об эффективности и безопасности применения бета-адреноблокаторов в лечении артериальной гипертензии (АГ). Рассматриваются вопросы влияния препаратов данной группы на частоту развития кардиоваскулярных событий,
G.D. Radchenko
core   +1 more source

Бета-адреноблокаторы: вопросы взаимодействия при местном и системном применении

, 2022
Glaucoma currently ranks first among the causes of irreversible blindness and low vision. Stabilization of the glaucomatous process, especially at its initial stages, can be achieved by using drug therapy to affect the proven risk factor — the level of ...
A. L. Onishchenko, D. I. Ivanova, I. S. Makogon, Д. И. Иванова, А. Л. Онищенко, С. И. Макогон   +5 more
core   +1 more source

TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE

Рациональная фармакотерапия в кардиологии, 2015
Topical issues of the treatment of hypertension in pregnancy are presented. Examples from clinical practice are discussed as well as possible medical treatment of hypertension in pregnant women taking into account actual recommendations.
O. V. Gaisenok, O. A. Zamyatina, N. Yu. Denisova, A. S. Leonov   +3 more
doaj   +1 more source

BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE

Рациональная фармакотерапия в кардиологии, 2015
Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented. The role of beta-blockers among other basic groups of antihypertensive drugs (thiazide diuretics, calcium channel blockers, ACE inhibitors) is evaluated ...
M. V. Leonova
doaj   +1 more source

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE

Рациональная фармакотерапия в кардиологии, 2015
Review is devoted to the role of modern beta-blocker nebivolol in the treatment of stable ischemic heart disease (IHD). The mode of nebivolol anti-ischemic activity is considered, as well as its use particularities in IHD patients with different ...
V. P. Lupanov
doaj   +1 more source

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL

Рациональная фармакотерапия в кардиологии, 2016
Aim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study.
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich   +26 more
doaj   +1 more source

IZUChENIE PLEYOTROPNYKh EFFEKTOV V-ADRENOBLOKATOROV I INGIBITOROV APF NA KOSTNUYu TKAN'

Остеопороз и остеопатии, 2014
Objective: To investigate the effect of treatment with betablockers (β-AB), inhibitors of angiotensin converting enzyme (ACEI) on bone mineral density (BMD) depending on the risk factors (RF) of osteoporosis. Material and methods.
I A SKRIPNIKOVA, K E SOBChENKO, E S ABIROVA, V E NOVIKOV, T V POPKOVA, I S DYDYKINA, V A VYGODIN, A V SMIRNOV   +7 more
doaj   +1 more source

Metoprolol tartrate. Сlinical use

Медицинский совет, 2015
It's hard to imagine cardiology which would not make use of beta-blockers. The medical arsenal contains a myriad of products which differ from each other by their pharmacodynamic and pharmacokinetic properties.
A. A. Zateischikova
doaj   +1 more source